India’s Covaxin shot 78 percent effective against coronavirus
FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech’s COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi/File Photo
India’s Covaxin shot 78% effective against coronavirus, say developers
NEW DELHI (Reuters) – India’s only domestically developed COVID-19 vaccine, Covaxin, has been found to be 78% effective in a second analysis of clinical trials done around the country, its makers said here on Wednesday.
“I am very pleased to state that Covaxin … has shown the efficacy of 78% in the second interim analysis,” said Balram Bhargava, the chief of the state-run Indian Council of Medical Research that has created the vaccine with Bharat Biotech.
The first analysis released in March had shown an efficacy rate of 81%.
Reporting by Krishna N. Das; Editing by Hugh Lawson
Our Standards: The Thomson Reuters Trust Principles.
Reuters source:
